Adult chronic rhinosinusitis

C Bachert, B Marple, RJ Schlosser, C Hopkins… - Nature reviews Disease …, 2020 - nature.com
Chronic rhinosinusitis (CRS) occurs in> 10% of the adult population in Europe and the USA
and can be differentiated into CRS without nasal polyps and CRS with nasal polyps …

Yardstick for the medical management of chronic rhinosinusitis

L Borish, FM Baroody, MS Kim, JA Lieberman… - Annals of Allergy …, 2022 - Elsevier
Chronic rhinosinusitis (CRS) is an inflammatory condition of the paranasal sinuses defined
by classic symptoms, imaging findings, or endoscopic findings. There are a growing number …

Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps

D Wu, B Yan, Y Wang, C Wang, L Zhang - Journal of Allergy and Clinical …, 2021 - Elsevier
Background Integrated care pathways improve the management of patients with chronic
rhinosinusitis with nasal polyps (CRSwNP). The application of integrated care pathways …

[HTML][HTML] Changes in clinical and histological characteristics of nasal polyps in northern China over the past 2–3 decades

J Yu, M Xian, Y Piao, L Zhang, C Wang - International Archives of …, 2021 - karger.com
Introduction: Recent studies have shown that inflammatory patterns of nasal polyps from
patients with chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) in East Asia have …

Current and emerging treatment options in sinus and nasal diseases: a promising future in the appropriate therapies

L Lin, L Cheng - Journal of Clinical Medicine, 2022 - mdpi.com
Chronic rhinosinusitis (CRS) is an inflammatory condition of the nose and paranasal sinuses
defined by clinical symptoms, including two or more symptoms, one of which should be …

Effects of fluticasone exhalation delivery system in patients with chronic rhinosinusitis with nasal polyps: a systematic review

D Wu, T Huang, Y Wei - American Journal of Rhinology & …, 2022 - journals.sagepub.com
Background Nasal sprays with corticosteroids deliver medication to the restricted areas
including anterior and inferior parts of the nasal cavity. The fluticasone exhalation delivery …

Abordaje diagnóstico del asma difícil de tratar y asma grave

M Venancio-Hernández, E Mendieta-Flores… - Revista alergia …, 2022 - scielo.org.mx
El asma difícil de tratar es la que no se controla a pesar de las dosis altas o medias de
esteroides inhalados o la que requiere altas porciones para mantener un control adecuado …

[HTML][HTML] Systemic Corticosteroid–related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal …

GE Davis, RS Zeiger, B Emmanuel, Y Chung… - Clinical Therapeutics, 2022 - Elsevier
Abstract Purpose Nasal polyps (NPs) develop in 20% to 30% of patients with chronic
rhinosinusitis. Severe forms of chronic rhinosinusitis with nasal polyposis (CRSwNP) may be …

[HTML][HTML] GEMA 5.3. Spanish guideline on the management of asthma

VP Moral, I Alobid, CÁ Rodríguez, MB Aparicio… - Open Respiratory …, 2023 - Elsevier
Abstract The Spanish Guideline on the Management of Asthma, better known by its acronym
in Spanish GEMA, has been available for more than 20 years. Twenty-one scientific …

Topical nasal treatment efficacy on adult obstructive sleep apnea severity: a systematic review and meta‐analysis

DK Nguyen, J Liang, M Durr - International Forum of Allergy & …, 2021 - Wiley Online Library
Background Nasal obstruction is a common complaint in patients with sleep‐disordered
breathing and obstructive sleep apnea (OSA). Although topical nasal treatments (TNTs) …